EUR 27.0
(-0.37%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 2.06 EUR | -19.84% |
2022 | 2.57 EUR | 57.67% |
2021 | 1.63 EUR | 8.67% |
2020 | 1.50 EUR | -35.34% |
2019 | 2.32 EUR | -28.17% |
2018 | 3.23 EUR | -24.0% |
2017 | 4.25 EUR | 0.71% |
2016 | 4.22 EUR | 5.24% |
2015 | 4.01 EUR | -13.2% |
2014 | 4.62 EUR | 8.96% |
2013 | 4.24 EUR | 79.66% |
2012 | 2.36 EUR | 19.8% |
2011 | 1.97 EUR | -2.48% |
2010 | 2.02 EUR | -27.34% |
2009 | 2.78 EUR | 55.31% |
2008 | 1.79 EUR | 43.2% |
2007 | 1.25 EUR | 165.96% |
2006 | 0.47 EUR | -41.98% |
2005 | 0.81 EUR | -27.03% |
2004 | 1.11 EUR | -19.57% |
2003 | 1.38 EUR | 11.29% |
2002 | 1.24 EUR | 16.98% |
2001 | 1.06 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.19 EUR | 0.0% |
2023 Q2 | 0.89 EUR | 0.0% |
2023 Q4 | 1.17 EUR | 0.0% |
2023 FY | - EUR | -19.84% |
2022 Q2 | 0.72 EUR | 0.0% |
2022 Q4 | 1.85 EUR | 0.0% |
2022 FY | - EUR | 57.67% |
2021 FY | - EUR | 8.67% |
2021 Q4 | 2.17 EUR | 0.0% |
2021 Q2 | -0.54 EUR | 0.0% |
2020 Q2 | -0.06 EUR | 0.0% |
2020 Q4 | 1.55 EUR | 0.0% |
2020 FY | - EUR | -35.34% |
2019 FY | - EUR | -28.17% |
2019 Q4 | 2.34 EUR | 0.0% |
2019 Q2 | -0.02 EUR | 0.0% |
2018 Q2 | 1.20 EUR | 0.0% |
2018 FY | - EUR | -24.0% |
2018 Q4 | 2.05 EUR | 0.0% |
2017 Q2 | 1.35 EUR | 0.0% |
2017 Q4 | 2.90 EUR | 0.0% |
2017 FY | - EUR | 0.71% |
2016 FY | - EUR | 5.24% |
2016 Q2 | 1.44 EUR | 0.0% |
2016 Q4 | 2.78 EUR | 0.0% |
2015 Q4 | 2.85 EUR | 0.0% |
2015 Q2 | 1.16 EUR | 0.0% |
2015 FY | - EUR | -13.2% |
2014 Q2 | 1.00 EUR | 0.0% |
2014 FY | - EUR | 8.96% |
2014 Q4 | 3.65 EUR | 0.0% |
2013 Q2 | 1.32 EUR | 0.0% |
2013 FY | - EUR | 79.66% |
2013 Q4 | 2.92 EUR | 0.0% |
2012 Q2 | 0.58 EUR | 0.0% |
2012 FY | - EUR | 19.8% |
2012 Q1 | 0.58 EUR | 0.0% |
2012 Q3 | 0.58 EUR | 0.0% |
2012 Q4 | 1.06 EUR | 82.76% |
2011 Q2 | 0.49 EUR | 0.0% |
2011 FY | - EUR | -2.48% |
2011 Q4 | 0.58 EUR | 18.37% |
2011 Q1 | 0.49 EUR | 0.0% |
2011 Q3 | 0.49 EUR | 0.0% |
2010 Q2 | 0.50 EUR | 0.0% |
2010 FY | - EUR | -27.34% |
2010 Q4 | 0.49 EUR | -2.0% |
2010 Q3 | 0.50 EUR | 0.0% |
2010 Q1 | 0.50 EUR | 0.0% |
2009 Q2 | 0.69 EUR | 0.0% |
2009 Q3 | 0.69 EUR | 0.0% |
2009 Q4 | 0.50 EUR | -27.54% |
2009 FY | - EUR | 55.31% |
2009 Q1 | 0.69 EUR | 0.0% |
2008 FY | - EUR | 43.2% |
2008 Q4 | 0.69 EUR | 53.33% |
2008 Q3 | 0.45 EUR | 0.0% |
2008 Q2 | 0.45 EUR | 0.0% |
2008 Q1 | 0.45 EUR | 0.0% |
2007 Q3 | 0.31 EUR | 0.0% |
2007 Q2 | 0.31 EUR | 0.0% |
2007 Q1 | 0.31 EUR | 0.0% |
2007 Q4 | 0.45 EUR | 45.16% |
2007 FY | - EUR | 165.96% |
2006 Q4 | 0.31 EUR | 158.33% |
2006 Q3 | 0.12 EUR | 0.0% |
2006 Q2 | 0.12 EUR | 0.0% |
2006 Q1 | 0.12 EUR | 0.0% |
2006 FY | - EUR | -41.98% |
2005 FY | - EUR | -27.03% |
2005 Q4 | 0.12 EUR | -40.0% |
2005 Q3 | 0.20 EUR | 0.0% |
2005 Q2 | 0.20 EUR | 0.0% |
2005 Q1 | 0.20 EUR | 0.0% |
2004 FY | - EUR | -19.57% |
2004 Q4 | 0.20 EUR | -28.57% |
2004 Q3 | 0.28 EUR | 0.0% |
2004 Q2 | 0.28 EUR | 0.0% |
2004 Q1 | 0.28 EUR | 0.0% |
2003 Q4 | 0.28 EUR | -17.65% |
2003 FY | - EUR | 11.29% |
2003 Q3 | 0.34 EUR | 0.0% |
2003 Q2 | 0.34 EUR | 0.0% |
2003 Q1 | 0.34 EUR | 0.0% |
2002 Q1 | 0.31 EUR | 0.0% |
2002 FY | - EUR | 16.98% |
2002 Q4 | 0.34 EUR | 9.68% |
2002 Q3 | 0.31 EUR | 0.0% |
2002 Q2 | 0.31 EUR | 0.0% |
2001 FY | - EUR | 0.0% |
2001 Q1 | 0.26 EUR | 0.0% |
2001 Q2 | 0.26 EUR | 0.0% |
2001 Q3 | 0.26 EUR | 0.0% |
2001 Q4 | 0.31 EUR | 19.23% |
2000 Q4 | 0.26 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Laboratorios Farmaceuticos Rovi, S.A. | 3.20 EUR | 35.625% |
Vetoquinol SA | 4.70 EUR | 56.17% |
Valneva SE | -0.73 EUR | 382.192% |
AB Science S.A. | -0.20 EUR | 1130.0% |
Nanobiotix S.A. | -1.08 EUR | 290.741% |
PHAXIAM Therapeutics S.A. | -5.00 EUR | 141.2% |
Vivoryon Therapeutics N.V. | -1.12 EUR | 283.929% |
BioSenic S.A. | -0.21 EUR | 1080.952% |
ABIVAX Société Anonyme | -3.43 EUR | 160.058% |
Formycon AG | 4.76 EUR | 56.723% |